We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

83 hedge funds and large institutions have $239M invested in Avadel Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

67% more capital invested

Capital invested by funds: $143M → $239M (+$96.3M)

14% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 22

12% more call options, than puts

Call options by funds: $13.7M | Put options by funds: $12.3M

9% more funds holding

Funds holding: 76 → 83 (+7)

1% more ownership

Funds ownership: 53.16% → 54.15% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
83
Holders Change
+7
Holders Change %
+9.21%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
25
Reduced
22
Closed
7
Calls
$13.7M
Puts
$12.3M
Net Calls
+$1.46M
Net Calls Change
+$4.89M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$8.47M
2
TLP
Tri Locum Partners
New York
+$4.8M
3
Millennium Management
Millennium Management
New York
+$4.27M
4
WP
Woodline Partners
California
+$3.62M
5
GJL
Gendell Jeffrey L
+$2.34M

Top Sellers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
-$7.32M
2
MB
MPM BioImpact
Massachusetts
-$2.07M
3
VC
Vivo Capital
California
-$1.28M
4
Two Sigma Investments
Two Sigma Investments
New York
-$743K
5
Renaissance Technologies
Renaissance Technologies
New York
-$723K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAS
51
Kestra Advisory Services
Texas
$112K -$219K -31,250 -67%
VF
52
Virtu Financial
New York
$110K +$33.4K +4,769 +45%
BRWA
53
B. Riley Wealth Advisors
Florida
$107K – – –
DS
54
DRW Securities
Illinois
$107K +$105K +15,000 New
BSW
55
Buckingham Strategic Wealth
Missouri
$98.2K – – –
DIG
56
DeepCurrents Investment Group
New York
$95.1K – – –
LWAM
57
Legacy Wealth Asset Management
Minnesota
$93.1K – – –
CAN
58
Cetera Advisor Networks
California
$90.7K – – –
AWA
59
Aaron Wealth Advisors
Illinois
$90.5K +$88.6K +12,642 New
AAS
60
Avantax Advisory Services
Texas
$89.5K -$7.01K -1,000 -7%
KI
61
Kapitalo Investimentos
Brazil
$85.9K +$84.1K +12,000 New
Parallax Volatility Advisers
62
Parallax Volatility Advisers
California
$79.2K +$77.5K +11,058 New
JSW
63
Journey Strategic Wealth
New Jersey
$71.6K – – –
Wells Fargo
64
Wells Fargo
California
$60.9K -$21.1K -3,005 -26%
PI
65
PineBridge Investments
New York
$52.3K – – –
TRCT
66
Tower Research Capital (TRC)
New York
$45K -$56.9K -8,114 -56%
LFG
67
Larson Financial Group
Missouri
$28.6K – – –
Rockefeller Capital Management
68
Rockefeller Capital Management
New York
$26K +$23.1K +3,294 +659%
Zurich Cantonal Bank
69
Zurich Cantonal Bank
Switzerland
$21.2K -$3.93K -561 -16%
UBS Group
70
UBS Group
Switzerland
$20.9K -$63.3K -9,029 -76%
SPIA
71
Steward Partners Investment Advisory
New York
$16.5K – – –
LC
72
Lindbrook Capital
California
$13.6K -$1.32K -188 -9%
HFM
73
Hartford Financial Management
Connecticut
$7.16K – – –
BCV
74
Banque Cantonale Vaudoise
Switzerland
$7K – – –
Citigroup
75
Citigroup
New York
$5.22K +$491 +70 +11%
1 2
3
4

AVDL Hedge Fund Activity: Q4 2022 in Review

83 of the 6,224 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q4 2022, worth a combined $239M — up 67% from $143M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AVDL positions and 7 closed out — a net gain of 9 holders — while 25 added to existing stakes and 22 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $8.47M. The largest seller was Brandes Investment Partners, cutting an estimated $7.32M.

  • 83 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q4 2022, up from 76 in Q3 2022.
  • Funds reported $239M of Avadel Pharmaceuticals stock for Q4 2022, up 67% quarter-over-quarter.
  • 16 funds opened new Avadel Pharmaceuticals positions in Q4 2022 and 7 closed out, a net change of +9 holders.
  • The largest Avadel Pharmaceuticals buyer in Q4 2022 was Janus Henderson Group, an estimated $8.47M added.
  • The largest Avadel Pharmaceuticals seller in Q4 2022 was Brandes Investment Partners, an estimated $7.32M sold.

Based on aggregated 13F filings for Q4 2022.